2005
DOI: 10.1007/s00535-004-1510-y
|View full text |Cite
|
Sign up to set email alerts
|

Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease

Abstract: These data suggest that the IL-15 and IL-15R system may play important roles in the activation and differentiation of lamina propria B cells in patients with IBD, especially in those with UC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
30
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(35 citation statements)
references
References 41 publications
4
30
1
Order By: Relevance
“…This postulation needs to be investigated in future studies. Although IL-15 was initially thought to be upregulated in predominantly Th1 cell diseases, such as rheumatoid arthritis 46 and inflammatory bowel disease, 47 results of studies demonstrated a role of IL-15 in asthma 48,49 which has long been considered a Th2-predominant disease. Studies by Meresse et al 50 and Tang et al 51 found that IL-15 plays a key role in amplifying this cytolysis reaction, which is mediated by cysteinyl leukotrienes, which are involved in asthma.…”
Section: Discussionmentioning
confidence: 99%
“…This postulation needs to be investigated in future studies. Although IL-15 was initially thought to be upregulated in predominantly Th1 cell diseases, such as rheumatoid arthritis 46 and inflammatory bowel disease, 47 results of studies demonstrated a role of IL-15 in asthma 48,49 which has long been considered a Th2-predominant disease. Studies by Meresse et al 50 and Tang et al 51 found that IL-15 plays a key role in amplifying this cytolysis reaction, which is mediated by cysteinyl leukotrienes, which are involved in asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Regardless of whether genetic or acquired factors are responsible for the increased permeability, therapies in each are equally possible and should be considered. 34 …”
Section: Inflamm Bowel Dismentioning
confidence: 97%
“…Research indicates that disruption of tight junctions, which normally seal epithelial cells and thereby control gut barrier function, is a characteristic of UC, with increased gut permeability reported in several studies of UC patients (Table 1). 20 -22 Cytokine production is also altered in UC (Table 2), with a large number of studies [23][24][25][26][27][28][29][30][31][32][33][34] finding that increased levels of proinflammatory and anti-inflammatory cytokines are associated with 1BD and its severity. Consequently, some researchers have suggested that this altered cytokine profile is responsible for modulating epithelial gut permeability (Table 3).…”
Section: Differences Between Uc and CD In Gut Permeabilitymentioning
confidence: 99%
“…Pro-inflammatory cytokines within this group, such as IL-2, IL-6, IL-15, IL-21, IL-23, IL-17 and IL-18, have been demonstrated to be detrimental in mice models of IBD [93,97,110,111,112,113,114,115,116,117,118]. While anti-inflammatory cytokines within this group, such as IFNα/β, IL-10, IL-11 and IL-22, were shown to be beneficial in animal models of IBD, their administration did not show any significant beneficial effects in patients with IBD [119,120,121,122,123,124,125,126].…”
Section: Stat3 and Inflammatory Bowel Diseasementioning
confidence: 99%